已收录 273763 条政策
 政策提纲
  • 暂无提纲
Serum protein S-100B as a novel biomarker of diagnosis and prognosis of childhood epilepsy
[摘要] BackgroundElevated levels of S-100B in serum are increasingly considered a potential biochemical marker of nervous system damage. To our knowledge, limited number of research studies have tested the serum S-100B protein levels in children with epilepsy. The objective of our study is to measure the serum levels of S-100B protein in pediatric cases with epilepsy.ResultsThe mean serum concentration of S-100B protein was 0.135 ± 0.014 mg/L in the patient group and 0.082 ± 0.018 mg/L in the control group. The patients showed significantly high S-100B protein levels compared with healthy controls (P < 0.001).ConclusionOur data suggest that increased S-100B protein levels in the serum potentially indicate neuronal damage in the brains of children with epilepsy.
[发布日期] 2022-12-31 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Childhood epilepsy;S-100B level;Biological marker;Children [时效性] 
   浏览次数:7      统一登录查看全文      激活码登录查看全文